TIRZ10 (SKU: TZ10)
Tirzepatide
Each Vial contains 10mg of product
Tirzepatide is a "dual agonist" peptide, meaning it targets two different receptors in the body simultaneously: the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. By mimicking these two natural metabolic hormones, it provides a multi-faceted approach to researching energy balance and systemic metabolism.
Primary Research Focus
Tirzepatide is one of the most active areas of study in metabolic science today. Researchers are exploring its potential in the following areas:
Synergistic Glycemic Control: Scientists study how activating both GIP and GLP-1 receptors may be more effective than targeting just one. Research focuses on how this "dual-action" helps the pancreas release insulin more efficiently in response to glucose levels.
Appetite and Satiety Signaling: Laboratory models are used to investigate how Tirzepatide affects the brain’s "reward center" and hunger signals. Researchers look at how it might slow down stomach emptying to prolong feelings of fullness.
Weight and Fat Metabolism: Beyond just appetite, researchers study how the GIP component specifically interacts with fat cells. Studies explore whether it can improve how the body breaks down stored fat and utilizes energy.
Cardiovascular and Organ Health: New research is expanding to see if Tirzepatide has protective effects on the heart, liver, and kidneys, specifically looking at its impact on inflammation and fat accumulation in these organs.